Delivery Order SPE2DB25D3306-SPE2DB25FUCFY
Award Date 7/17/25
Potential Completion Date 8/7/25
Potential Value $1.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,881.36 delivery order contract is for the supply of XOLAIR 150 MG/ML SYRINGEML, a medical product, with a performance period through July 18, 2025. The contract is a firm fixed-price delivery order, not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- This federal contract award is for the delivery of XOLAIR 150 MG/ML SYRINGEML to the Defense Logistics Agency (DLA), a defense agency. The $34,576.32 firm fixed-price delivery order contract has a performance period ending on July 14, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,688.08 firm fixed price delivery order is for the supply of XOLAIR 150 MG/ML SYRINGEML, a pharmaceutical product. The contract has a period of performance through May 28, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This federal contract award is for the delivery of XOLAIR 150 MG/ML SYRINGE/ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Medical Supply Chain. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, in the amount of $72,034. The contract is a delivery order with a firm fixed price and an ultimate completion date of August 6, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,688.10 fixed-price delivery order is for XOLAIR 150 MG/ML syringes, a pharmaceutical product. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as...
- This federal contract award is a delivery order valued at $5,762.72 for the pharmaceutical product XOLAIR 150 MG/ML SYRINGEML. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The award is not set aside and is a firm fixed-price contract with a completion date of July 22, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of XOLAIR 150 MG/ML SYRINGEML, a pharmaceutical product. The $10,128.48 Firm Fixed Price contract has a completion date of June 4, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
- This federal contract award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,440.70 delivery order contract is for the supply of XOLAIR 150 MG/ML SYRINGEML, a pharmaceutical product. The contract is a firm fixed price, non-set-aside award with a period of performance through July 1, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of XOLAIR 150 MG/ML SYRINGEML. The $3,376.16 firm fixed-price delivery order has a completion date of June 4, 2025 and is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a global pharmaceutical...
- This is a $2,161.02 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply XOLAIR 150 MG/ML SYRINGEML. The contract has an ultimate completion date of August 6, 2025 and was not set aside for any specific business size or type. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a wide range of pharmaceutical...